Researchers from Mount Sinai looked at the link between PFAS - found in everything from non-stick cookware to food packaging ...

GLP-1 drugs came out in 2005 as a Type 2 diabetes treatment. But in recent years their popularity for weight loss -- and the cost -- has taken off.

GLP-1 drugs like semaglutide (Ozempic) and tirzepatide (Mounjaro) may shrink fat, but also crucial muscle mass, with little evidence of improving cardiorespiratory fitness, researchers say.

Sometimes the techniques you use to relieve stress can make stress worse or lead to other problems. Learn the pitfalls and ...

A new genetic analysis using data from over five million people has provided a clearer understanding of the risk of going on to live with obesity.  New research led by the Universities of Copenhagen ...

More data, this time from a large observational study, are bolstering the idea that glucagon-like peptide-1 (GLP-1) receptor ...

The Society for Pediatric Dermatology’s 50th Annual Meeting will highlight advances in pediatric skin, hair, and nail care, ...

Social determinants of health significantly increased mortality risks in patients with congestive heart failure, highlighting urgent care needs.

So perhaps state intervention is the only policy British people are willing to accept. Understandably, they want the freedom ...

Pfizer and Novo Nordisk have underperformed the market over the past year. Pharmaceutical giants Pfizer (NYSE: PFE) and Novo ...

A genetic test may one day predict a child’s risk of obesity in adulthood, paving the way for early interventions.

Tirzepatide improves outcomes in patients with obesity-related HFpEF regardless of the severity of their baseline BMI or fat ...